CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 472 enrolled
Drug / intervention
CGMother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03842683
NCT03842683N/ACompleted

Are Todays Continuous Glucose Monitoring Precise and Can They be Used to Reveal and Reduce Glycaemic Variability?

Peter Vestergaard·observational·Posted Feb 15, 2019·Updated Nov 20, 2019

In Brief

An observational study evaluating CGM for Diabetes Type 1. Completed, enrolled 472 participants.

Detailed Summary

Use of devices for continuous monitoring of the blood sugar is valuable for people with diabetes to understand their disease and to help prevent low blood sugar. Furthermore, continuous monitoring should be used in drug development to evaluate efficacy and safety. However, the devices have been criticised for being too inaccurate. This investigation sought to reveal the inaccuracies of current devices and to assess the subsequent usability related to the mentioned use cases.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetes Type 1
Countries--
Collaborators--

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedFeb 15, 2019
Enrollment StartJun 6, 2016
Primary CompletionJun 20, 2017
TodayJul 2, 2026
Enrollment to primary: 1.0 yearsPosted 7.4 years ago

Interventions

CGMother

This study seeks to assess CGM accuracy and develop prediction models for hypoglycemia detection and no intervention is therefore applied.